<iframe src="//www.googletagmanager.com/ns.html?id=GTM-MX3DVL" height="0" width="0" style="display:none;visibility:hidden"></iframe>Pestalozzi advised Cilag Holding AG on the USD 2.3 billion cash tender offer for Crucell NV | Pestalozzi Attorneys at Law

Pestalozzi advised Cilag Holding AG on the USD 2.3 billion cash tender offer for Crucell NV

10.2010

Johnson & Johnson, through its affiliate Cilag Holding AG, and Crucell NV acquired all outstanding equity of Crucell that it does not already own. Crucell is a global biopharmaceutica company focused on the research & development, production and marketing of vaccines and antibodies against infectious disease worldwide. Pestalozzi acted as advisor to Johnson & Johnson and Cilag.

To the top

Cookies

Okay
We use cookies in order to optimally design and continuously improve our website. By continuing to use the website you consent to the use of cookies. For further information about cookies please view our data protection statement.